Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 1
Submit an article Journal homepage
199
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK

Jon Karnon School of Health and Related Research (ScHARR), University of Sheffield, UKCorrespondence[email protected]
,
Alan Brennan School of Health and Related Research (ScHARR), University of Sheffield, UK
,
Abdullah Pandor School of Health and Related Research (ScHARR), University of Sheffield, UK
,
Gerry Fowkes Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh, UK
,
Amanda Lee Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh, UK
,
David Gray Division of Cardiovascular Medicine, University Hospital, Queen's Medical Centre, Nottingham, UK
,
Catherine Coshall Department of Public Health Sciences, Guy's, King's and St Thomas’ School of Medicine, King's College London, UK
,
Charles Nicholls Evidence Research Unit, CMC Ltd, Macclesfield, UK
&
Ron Akehurst School of Health and Related Research (ScHARR), University of Sheffield, UK
 show all
Pages 101-112 | Accepted 02 Dec 2004, Published online: 23 Dec 2004

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Dirk Müller, Andreas Gerber-Grote, Björn Stollenwerk, Stephanie Stock, Philipp W. P. Auweiler, Simon Frey, Charles Christian Adarkwah, Reina de Kinderen & Martin Hellmich. (2016) Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 619-627.
Read now
Daniel T Grima, Stephen T Brown, Laveena Kamboj, Kevin R Bainey, Ron Goeree, Paul Oh, Krishnan Ramanathan & Shaun G Goodman. (2014) Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada. ClinicoEconomics and Outcomes Research 6, pages 49-62.
Read now
Thiago Luis Scudeler, Paulo Cury Rezende & Whady Hueb. (2014) The cost–effectiveness of strategies in coronary artery disease. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 805-813.
Read now
Feng Pan, Luis Hernandez & Alex Ward. (2012) Cost-effectiveness of stroke treatments and secondary preventions. Expert Opinion on Pharmacotherapy 13:12, pages 1751-1760.
Read now
L. Nherera, N.W. Calvert, K. DeMott, S.E. Humphries, H.A.W. Neil, R. Minhas & M. Thorogood. (2010) Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia. Current Medical Research and Opinion 26:3, pages 529-536.
Read now
Marco Cattaneo. (2007) Platelet P2 receptors: old and new targets for antithrombotic drugs. Expert Review of Cardiovascular Therapy 5:1, pages 45-55.
Read now
Mark D Schleinitz. (2006) The cost–effectiveness of clopidogrel: a review by indication. Expert Review of Pharmacoeconomics & Outcomes Research 6:2, pages 123-130.
Read now

Articles from other publishers (23)

Doyeon Hwang, Hea-Lim Kim, Bon-Kwon Koo, Tae-Min Rhee, Dong-Wook Yang, Youngwon Seo, Joonsoo Byun, Jeehoon Kang, Jung-Kyu Han, Kyung Woo Park, Eun-Seok Shin, Seung-Woon Rha, Jang-Whan Bae, Mamas A. Mamas, David J. Cohen, Tae-Jin Lee & Hyo-Soo Kim. (2023) Cost-Effectiveness of Clopidogrel vs Aspirin Monotherapy After Percutaneous Coronary Intervention. JACC: Asia 3:2, pages 198-207.
Crossref
Yu Fu, Xin-yi Zhang, Si-bei Qin, Xiao-yan Nie, Lu-wen Shi, Hong Shao & Jian Liu. (2020) Cost–effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome . Pharmacogenomics 21:1, pages 33-42.
Crossref
Lei Zhang, Ziyi Lin, Hongjun Yin, Jing Liu & Jianwei Xuan. (2018) Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective. Clinical Therapeutics 40:12, pages 2125-2137.
Crossref
Elizabeth R. Stevens, Daniel Farrell, Saahil A. Jumkhawala & Joseph A. Ladapo. (2018) Quality of health economic evaluations for the ACC/AHA stable ischemic heart disease practice guideline: A systematic review. American Heart Journal 204, pages 17-33.
Crossref
Majd B Protty, Simon J Wilkins, Hannah C Hoskins, Ban B Dawood & Jamie Hayes. (2018) Prescribing patterns of oral antiplatelets in Wales: evolving trends from 2005 to 2016. Future Cardiology 14:4, pages 277-282.
Crossref
Ching-Yun Wei, Ruben G. W. Quek, Guillermo Villa, Shravanthi R. Gandra, Carol A. Forbes, Steve Ryder, Nigel Armstrong, Sohan Deshpande, Steven Duffy, Jos Kleijnen & Peter Lindgren. (2016) A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. PharmacoEconomics 35:3, pages 297-318.
Crossref
Yugo Chisaki, Nobuhiko Nakamura & Yoshitaka Yano. (2017) Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in Cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell Lung Cancer. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:1, pages 73-81.
Crossref
Te Li, Maobai Liu, He Ben, Zhenxing Xu, Han Zhong & Bin Wu. (2015) Clopidogrel Versus Aspirin in Patients with Recent Ischemic Stroke and Established Peripheral Artery Disease: An Economic Evaluation in a Chinese Setting. Clinical Drug Investigation 35:6, pages 365-374.
Crossref
Anil Vaidya, Manuela A Joore, Arina J ten Cate-Hoek, Hugo ten Cate & Johan L Severens. (2014) Screen or not to screen for peripheral arterial disease: guidance from a decision model. BMC Public Health 14:1.
Crossref
C. de Oliveira, H. V. Nguyen, H. C. Wijeysundera, W. W. L. Wong, G. Woo, P. Grootendorst, P. P. Liu & M. D. Krahn. (2013) Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis. CMAJ Open 1:2, pages E83-E90.
Crossref
Clarabelle Pham, Orla Caffrey, David Ben-Tovim, Paul Hakendorf, Maria Crotty & Jonathan Karnon. (2012) Evaluating the effects of variation in clinical practice: a risk adjusted cost-effectiveness (RAC-E) analysis of acute stroke services. BMC Health Services Research 12:1.
Crossref
Mario Monaco, Luigi Di Tommaso, Giovanni Battista Pinna, Stefano Lillo, Vincenzo Schiavone & Paolo Stassano. (2012) Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients. Journal of Vascular Surgery 56:1, pages 96-105.
Crossref
Chad Kessler, Kurian Thomas & John Kao. (2023) Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome, Transient Ischemic Attack, and Noncardioembolic Stroke in an Era of Cost Containment. Journal of Investigative Medicine 60:5, pages 792-800.
Crossref
Suzanne V. Arnold, David J. Cohen & Elizabeth A. Magnuson. (2011) Cost-effectiveness of oral antiplatelet agents—current and future perspectives. Nature Reviews Cardiology 8:10, pages 580-591.
Crossref
Arun Balakrishnan & David Lambert. 2011. Postgraduate Vascular Surgery. Postgraduate Vascular Surgery 49 57 .
E. Gkaliagkousi, G. Passacquale, S. Douma, C. Zamboulis & A. Ferro. (2010) Platelet Activation in Essential Hypertension: Implications for Antiplatelet Treatment. American Journal of Hypertension 23:3, pages 229-236.
Crossref
Dawn Meyer. (2009) Antiplatelets and Stroke Outcomes: State of the Science. Critical Care Nursing Clinics of North America 21:4, pages 517-528.
Crossref
Lee Goldman & Jean-Michel Gaspoz. (2008) Cost-Effectiveness of Clopidogrel: Seeing through the Smoke. Medical Decision Making 28:6, pages 803-809.
Crossref
Jonathan Karnon, Thomas Delea & Vicki Barghout. (2007) Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective. The European Journal of Health Economics 9:2, pages 171-183.
Crossref
John Brazier. (2008) Valuing Health States for Use in Cost-Effectiveness Analysis. PharmacoEconomics 26:9, pages 769-779.
Crossref
P. Priollet & G. de Pouvourville. (2007) Impact du?choix d'un antiagr?gant plaquettaire dans?l'art?riopathie oblit?rante des?membres inf?rieurs sur?les?pertes de?chances et?sur?les?co?ts m?dicaux. Journal des Maladies Vasculaires 32:1, pages 8-14.
Crossref
Greg L Plosker & Katherine A Lyseng-Williamson. (2007) Clopidogrel. Drugs 67:4, pages 613-646.
Crossref
Marco Cattaneo. 2007. Platelets. Platelets 1127 1144 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.